Virtus ETF Advisers’s Passage Bio PASG Stock Holding History

Virtus ETF Advisers’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,166	Closed	-$72K	–	464
2022 Q1	$72K	Sell	1,166 -69	-6%	-$5.69K	0.03%	347
2021 Q4	$157K	Buy	1,235 +501	+68%	+$81.8K	0.06%	335
2021 Q3	$146K	Sell	734 -39	-5%	-$9.3K	0.06%	348
2021 Q2	$205K	Buy	+773	New	+$239K	0.08%	328

Other funds holding PASG

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HCM

Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtus ETF Advisers's PASG Position: Q2 2022 in Review

Virtus ETF Advisers sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 1,166 shares — an estimated $72K sold.

Virtus ETF Advisers first reported a position in PASG in Q2 2021 and held it in 4 quarters. The position peaked at $205K in Q2 2021. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

Virtus ETF Advisers reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
Virtus ETF Advisers sold 1,166 Passage Bio shares in Q2 2022, an estimated $72K.
Virtus ETF Advisers first reported a position in Passage Bio in Q2 2021 and held it in 4 quarters.
Virtus ETF Advisers's Passage Bio position peaked at $205K in Q2 2021.
85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.